October 21st, 2014

Nationwide Lidocaine Recall

Nationwide Lidocaine Recall

October 21, 2014
Hospira has issued a nationwide recall of a single lot of 1% lidocaine HCI injection, according to a statement released by the U.S. Food and Drug Administration (FDA) on Thursday.

The discovery of particulate matter, determined to be human hair, was found in one of the units. It was “embedded in and attached to a pinched area of the stopper,” according to the statement.

The lot was distributed between May and June of this year.

No adverse events have been reported.

Anyone in possession of lot 40-316-DK (expiration date of April 1, 2016) should cease use and quarantine the product immediately.

This recall comes on the heels of a number of recalls Hosipra has issued. Last week, Hospira issued a nationwide recall of a number of IV solutions because of the possibility of leakage and contamination due to a puncture in the overwrap and primary container.

Hospira also issued a nationwide recall in early October of vancomycin for injection because of uncontrolled storage during transit.

In September, Hospira issued another recall of heparin sodium due to the discovery of particulate matter, which also turned out to be human hair.

For more information call: 1-800-441-4100.

References:

1. Hospira announces voluntary nationwide recall of one lot of 1% lidocaine HCI injection, USP 10 mg per ml, 30 ml single-dose. Preservative-free, due to particulate matter [press release]. www.fda.gov. 2014 Oct 18.

2. Hospira recalls IV solutions. Pharmacy Learning Network. 2014 Oct 15.

3. Vaccaro S. Antibiotic recall. Pharmacy Learning Network. 2014 Oct 8.

4. Vaccaro S. Heparin recall due to human hair. Pharmacy Learning Network. 2014 Sep 15.